Published January 1, 2016
| Version v1
Journal article
Open
Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation
Creators
- 1. Grand Valley State Univ, Dept Chem, Allendale, MI 49401 USA
- 2. Gumushane Univ, Dept Genet & Bioengn, Fac Engn & Nat Sci, Gumushane, Turkey
- 3. Recep Tayyip Erdogan Univ, Fac Med, Dept Med Microbiol, Rize, Turkey
- 4. Recep Tayyip Erdogan Univ, Microbiol & Mol Biol Res Lab, Dept Biol, Fac Arts & Sci, TR-53100 Rize, Turkey
Description
The class A p-lactamase GES-22 has been identified in Acinetobacter baumannii isolates in Turkey, and subsequently shown to differ from GES-11 by a single substitution (M169L). Because M169 is part of the omega loop, a structure that is known to have major effects on substrate selectivity in class A beta-lactamases, we expressed, purified and kinetically characterized this novel variant. Our results show that compared with GES-11(6xHis), GES-22(6xHis) displays more efficient hydrolysis of penicillins, and aztreonam, but a loss of efficiency against ceftazidime. In addition, the M169L substitution confers on GES-22 more efficient hydrolysis of the mechanistic inhibitors clavulanic acid and sulbactam. These effects are highly similar to other mutations at the homologous position in other class A beta-lactamases, suggesting that this methionine has a key structural role in aligning active site residues and in substrate selectivity across the class.
Files
bib-d48a6af0-80a6-498a-ab08-451c9baea4b0.txt
Files
(208 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:15e36d58136c6840e94f30b0236618b5
|
208 Bytes | Preview Download |